目的探讨血脂异常药物治疗的最佳方案。方法流行病学调查表明,不同国家或地区人群中TC水平不同,其冠心病发病率和病死率亦显著不同。一级、二级冠心病预防及冠脉病变回缩等大量资料无可争辩地证实TC及(或)LDL-C的升高是冠心病最主要的独立危险因素。结果各种干预治疗针对降低TC或LDL-C,对降低冠心病发病率、病死率及粥样斑块回缩具有肯定的效果。结论选用有效的降脂药物治疗可减少心脑血管事件的发生。 Objective To investigate the optimal treatment of dyslipidemia. Methods Epidemiological survey showed that different countries or regions in different levels of TC, the incidence of coronary heart disease and mortality were significantly different. Primary and secondary prevention of coronary heart disease and coronary artery retraction and other large amounts of data indisputably confirm that elevated TC and / or LDL-C is the most important coronary heart disease independent risk factors. Results A variety of interventions to reduce the TC or LDL-C, to reduce the incidence of coronary heart disease, mortality and atherosclerotic plaques have a positive effect. Conclusion The use of effective lipid-lowering drug therapy can reduce the incidence of cardiovascular events.